Jun Tie
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
Papers in
- Hepatology 26
- Liver Disease and Transplantation 20
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- MicroRNA in disease regulation 5
- Co-authors
- Daiming Fan (11 shared papers)Yongzhan Nie (6 shared papers)Yang Liu (1 shared paper)Yanhui Jia (1 shared paper)Dahai Hu (1 shared paper)Yunwei Wang (1 shared paper)Jinxin Zhang (1 shared paper)Yunshu Yang (2 shared papers)
- Journals
- Hepatology International (3 papers)Alimentary Pharmacology & Therapeutics (3 papers)Investigational New Drugs (2 papers)EClinicalMedicine (2 papers)Journal of Vascular and Interventional Radiology (2 papers)
- Partner nations
- China
In The Last Decade
Jun Tie
35 papers receiving 1.8k citations
Jun Tie's Hit Papers
Peers
Comparison fields: 5 of 90
- Cancer Research 550
- Geriatrics and Gerontology 132
- Hepatology 285
- Molecular Biology 328
- Oncology 113
Countries citing papers authored by Jun Tie
This map shows the geographic impact of Jun Tie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Tie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Tie more than expected).
Fields of papers citing papers by Jun Tie
This network shows the impact of papers produced by Jun Tie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Tie. The network helps show where Jun Tie may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Tie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Regulation of SIRT1 and Its Roles in Inflammation Hit paper breakdown → | 2022 | 510 |
| 2 | 2010 | 383 | |
| 3 | 2012 | 203 | |
| 4 | 2019 | 107 | |
| 5 | Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study Hit paper breakdown → | 2024 | 106 |
| 6 | 2014 | 71 | |
| 7 | 2015 | 55 | |
| 8 | 2017 | 45 | |
| 9 | 2014 | 44 | |
| 10 | 2009 | 42 | |
| 11 | 2011 | 41 | |
| 12 | 2018 | 36 | |
| 13 | 2017 | 28 | |
| 14 | 2019 | 22 | |
| 15 | 2010 | 17 | |
| 16 | 2010 | 14 | |
| 17 | 2011 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2016 | 11 | |
| 20 | 2018 | 10 |
About Jun Tie
Jun Tie is a scholar working on Hepatology, Cancer Research, Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Physiology, having authored 41 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver Disease and Transplantation (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), MicroRNA in disease regulation (5 papers), Gastric Cancer Management and Outcomes (3 papers), Telomeres, Telomerase, and Senescence (2 papers), Epigenetics and DNA Methylation (1 paper), Axon Guidance and Neuronal Signaling (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Cancer Research (550 citations), Geriatrics and Gerontology (132 citations), Hepatology (285 citations), Molecular Biology (328 citations) and Oncology (113 citations). Jun Tie has collaborated with scholars based in China. Frequent co-authors include Daiming Fan, Yongzhan Nie, Yang Liu, Yanhui Jia, Dahai Hu, Yunwei Wang, Jinxin Zhang, Yunshu Yang, Kaichun Wu and Lina Zhao. Their work appears in journals such as Hepatology International, Alimentary Pharmacology & Therapeutics, Investigational New Drugs, EClinicalMedicine and Journal of Vascular and Interventional Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.